Scientists have published the first detailed picture of the molecular structure of human telomerase, which will allow more targeted drug screens and intelligent design of new drugs.
Researchers have proposed a radical change in the way Alzheimer’s disease is defined, focusing on biological changes in the body, rather than clinical symptoms such as memory loss and cognitive decline.
New findings suggest that many senior citizens remain more cognitively and emotionally intact than commonly believed. This could perhaps provide clues as to how we can keep our minds sharper for longer.
The FDA has announced a plan to modernise its approach to evaluating new drugs for Alzheimer’s and other neurologic diseases.
New research suggests that the first modern Briton from 300 generations ago, had a darker complexion than first thought, as well as blue eyes and curly hair.
A simple technique to gauge brain levels of a toxic protein could improve diagnosis and drug trials, to help in the quest to diagnose and treat Alzheimer’s disease.
A drug developed for type 2 diabetes has “significantly reversed memory loss” in mice with Alzheimer’s disease, and researchers now want to test it on humans.
Scientists have identified differences in a group of genes they say might help explain why some people need a lot more sleep, and others less, than most.